Last Updated: November 5, 2026

ENOXAPARIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Enoxaparin patents expire, and when can generic versions of Enoxaparin launch?

Enoxaparin is a drug marketed by Amphastar Pharms Inc, Emerge Bioscience, Sandoz Inc, Amphastar Pharm, Be Pharms, Gland, Hebei Changshan, Sandoz, Shenzhen Techdow, and Zydus Pharms. and is included in eleven NDAs.

The generic ingredient in ENOXAPARIN is enoxaparin sodium. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Enoxaparin

A generic version of ENOXAPARIN was approved as enoxaparin sodium by SANDOZ INC on November 28th, 2011.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for ENOXAPARIN?
  • What are the global sales for ENOXAPARIN?
  • What is Average Wholesale Price for ENOXAPARIN?
Summary for ENOXAPARIN
US Patents:0
Applicants:10
NDAs:11
Drug Prices: Drug price information for ENOXAPARIN
DailyMed Link:ENOXAPARIN at DailyMed
Drug patent expirations by year for ENOXAPARIN
Drug Prices for ENOXAPARIN

See drug prices for ENOXAPARIN

Drug Sales Revenue Trends for ENOXAPARIN

See drug sales revenues for ENOXAPARIN

US Patents and Regulatory Information for ENOXAPARIN

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-004 Jul 23, 2010 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hebei Changshan ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 218775-001 Jan 7, 2026 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Shenzhen Techdow ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 205660-004 Mar 15, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-007 Jul 23, 2010 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Shenzhen Techdow ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 205660-005 Mar 15, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-003 Jun 23, 2014 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for ENOXAPARIN
Enoxaparin?
Who manufactures enoxaparin?
Generic name for enoxaparin?
Enoxaparin sodium manufacturer?
Enoxaparin cost?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links